 FLORHAM PARK, N.J., June 01, 2021 GLOBE NEWSWIRE -- PDS Biotechnology Corporation Nasdaq: PDSB, a clinical-stage immunotherapy company developing novel cancer therapies based on the Companys proprietary Versamune T-cell activating technology, today announced it will host an Oncology RD Day for analysts, investors, and the scientific community from 8:00 10:00 AM ET on Wednesday, June 16th. 